PSA Tests Cut Metastatic Prostate Cancer Rates by Half

Screening for early prostate cancer detection may reduce the rate of newly diagnosed  metastatic disease. In a published study researchers evaluated the incidence of a men receiving a diagnosis of metastatic prostate cancer at their initial prostate cancer diagnosis using data extracted from the Surveillance, Epidemiology, and End Results (SEER) Program database. Their analysis was [...]

U.S. Congress Passes Omnibus Funding with Significant Increases for Medical Research

We have some good news, the United States Congress has passed the Omnibus spending package.  The package will fund the U.S. Government through fiscal 2016.  We should take note that this bill includes a $2 billion increase for the National Institute of Health (NIH), a 5% increase for the National Cancer Institute (NCI) and the [...]

Some Good Funding News for the Prostate Cancer Community

The US Congress has just published the proposed Omnibus Budget for 2016. The good news is that the proposed budget includes the restoration of the 13.2 million dollars to the Centers for Disease Control (CDC)  for Prostate Cancer Prevention and Education and it also includes 80 million dollars for the Department of Defense Prostate Cancer [...]

By |2015-12-17T14:01:36-05:00December 17th, 2015|Advanced Prostate Cancer, Advocacy, CDC, DOD, Uncategorized|0 Comments

An Outrage in Leeds England – Prostate Cancer Survivor First Misdiagnosed & Then Stuck With £1,400 Bill For Chemotherapy

A story written by Dominic Horsley and published in the Yorkshire Evening Post claims that in May a 41 year old prostate cancer survivor from Woodlesford was referred to specialists at Leeds St James’s Hospital. He claimed that he had aches in his lower body but says t consultants told him that he was told [...]

Payment for PSA Prostate Cancer Screening may end

Believe it or not, in this week approaching Thanksgiving, we in the United States are faced with a second challenge to Prostate Cancer screening using the PSA test. Malecare wants you to know.   The Centers for Medicare and Medicaid Services (CMS) is asking for pubic comment on a clinical quality measure that would probably [...]

By |2021-02-22T10:05:35-05:00November 15th, 2015|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments
Go to Top